SHANDONG SANYUAN BIOTECHNOLOGY CO.,LTD.

News Shandong Sanyuan Biotechnology Co.,Ltd.

Equities

301206

CNE100005774

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
32.5 ^CNY	+6.77%		+14.76%	+12.53%

Apr. 22	Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 10	Certain A Shares of Shandong Sanyuan Biotechnology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 10-FEB-2024.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 22	CI
Certain A Shares of Shandong Sanyuan Biotechnology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 10-FEB-2024.	Feb. 09	CI
EU Opens Anti-Dumping Probe Into Sanyuan Biotechnology’s Erythritol Products	Nov. 28	MT
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-18	CI
Shandong Sanyuan Biotechnology Co.,Ltd.(XSEC:301206) added to S&P Global BMI Index	23-09-18	CI
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Shandong Sanyuan Biotechnology Co.,Ltd. Implements Final Profit Distribution Plan (A Shares) for 2022, Payable on 21 June 2023	23-06-14	CI
Shandong Sanyuan Biotechnology Co.,Ltd. Approves Cash Dividend for the Year 2022	23-05-19	CI
Shandong Sanyuan Biotechnology Co.,Ltd. Proposal Final Cash Dividend for 2022	23-04-27	CI
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-26	CI
Hapioneer announced that it has received $8.200000 million in funding from Shandong Sanyuan Biotechnology Co.,Ltd. and other investors.	22-10-24	CI
Shandong Peixue Bioengineering Co., Ltd. announced that it expects to receive CNY 60 million in funding from Shandong Sanyuan Biotechnology Co.,Ltd.	22-10-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
301206 Stock
News Shandong Sanyuan Biotechnology Co.,Ltd.

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW